Virology News and Research

Latest Virology News and Research

Japanese data suggests a protocol for schools to follow during H1N! pandemic

As flu season approaches, parents around the country are starting to face school closures. But how bad should an influenza outbreak be for a school to shut down? A study led by epidemiologists John Brownstein, PhD, and Anne Gatewood Hoen, PhD of the Children's Hospital Boston Informatics Program, in collaboration Asami Sasaki of the University of Niigata Prefecture (Niigata, Japan), tapped a detailed set of Japanese data to help guide decision making by schools and government agencies.

5 Nov 2009

Phadia offers ImmunoCAP, a reliable test to accurately diagnose the severity of egg allergy

The World Health Organization recently declared H1N1 swine flu a global pandemic, resulting in the creation of rigorous vaccination programs worldwide. Children are among those considered particularly susceptible to contracting swine flu and are viewed as a top priority in receiving this vaccine.

5 Nov 2009

Online self-assessment tool on MayoClinic.com helps assess flu symptoms

The flu symptoms self-assessment tool on MayoClinic.com helps you assess whether you or your loved ones have some form of flu, or just a cold. If you possibly or likely have the flu, you'll also learn whether antiviral medication is an option. And you can check a concise list of high-risk groups who should seek medical attention for the flu.

5 Nov 2009

NIAID funds CCHI and IMVC programs to help identify new vaccines for emerging infectious diseases

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases, including those that may be introduced into a community through acts of bioterrorism.

5 Nov 2009

USPTO awards Peregrine Pharmaceuticals patent for anti-viral uses of phosphatidylserine targeting antibodies

Peregrine Pharmaceuticals, Inc. today announced that the U.S. Patent and Trademark Office has issued U.S. Patent Number 7,611,704, which includes broad claims covering anti-viral uses of phosphatidylserine (PS)-targeting antibodies including Peregrine's lead clinical compound, bavituximab. PS is a unique marker exposed on the surface of virally infected cells that can be targeted to treat a broad spectrum of virus infections.

5 Nov 2009

House legislation seeks 5 days of sick leave for workers

In an effort to rein in the spread of the H1N1 Flu, Representative George Miller, the chairman of the House Education and Labor Committee, introduced legislation on Tuesday that would guarantee five paid sick days for workers sent home by their employers with a contagious illness. Mr. Miller, Democrat of California, voiced concern that more than 40 million workers did not have paid sick days and that many workers coming into contact with public — like restaurant or school cafeteria employees — would go to work with H1N1 and spread the virus if they could not afford to stay home.

5 Nov 2009

One Health Commission summit to focus on emerging infectious diseases

The growing threat of the H1N1 pandemic and West Nile virus -- as well as other emerging zoonotic, food, or waterborne diseases and environmental changes -- has prompted experts to look for solutions to the increasingly integrated problems among animal, human, and environmental health.

5 Nov 2009

News outlets examine international efforts to contain H1N1

A WHO official on Tuesday backed the Afghan government's decision to declare H1N1 (swine flu) a health emergency, forcing the closure of all schools in the country for three weeks in an effort to contain the virus, IRIN reports.

4 Nov 2009

Medivir presents OPERA-1 Phase IIa trial data at the AASLD meeting

Data were presented from the phase IIa trial (OPERA-1) for TMC435 at the ongoing 60th annual meeting of the American Association for the Study of Liver Diseases in Boston, USA.

4 Nov 2009

Henry Schein announces record financial results for third quarter 2009; reports net sales growth in local currencies

Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended September 26, 2009.

4 Nov 2009

Study results of nucleoside polymerase and protease inhibitor combination therapy for HCV promising

All approved therapy regimens to treat patients with hepatitis C are based on interferon, which must be injected. In this clinical trial to be presented at the annual meeting of the American Association for the Study of Liver Diseases, researchers treated patients - both treatment naive and experienced patients - with a twice daily oral combination therapy of a nucleoside polymerase and protease inhibitor.

4 Nov 2009

Hospitalization and death of H1N1 patients can occur at all ages, says study

In contrast with some common perceptions regarding 2009 influenza A(H1N1) infections, an examination of cases in California indicates that hospitalization and death can occur at all ages, and about 30 percent of hospitalized cases have been severe enough to require treatment in an intensive care unit, according to a study in the November 4 issue of JAMA.

4 Nov 2009

Five-year old Pennsylvanian boy dies of H1N1 flu complications

The Department of Health today confirmed that a five-year old Adams County boy died on Oct. 31 as a result of complications from H1N1 flu. This is Pennsylvania's first pediatric death associated with H1N1.

4 Nov 2009

H1N1 has increased focus on effect of hygiene on health

H1N1 has led to increased focus on how everyday hygiene affects our health. Not only is more attention given to managing personal hygiene, but a new cleaning logic is emerging, where wiping the door knob an extra time1 each day is considered more important than picking up the dust in the corner.

4 Nov 2009

Some patients with tonsil cancer can be treated with radiation, says PMH study

Clinical researchers at Princess Margaret Hospital (PMH) have confirmed that patients with oropharyngeal squamous cell cancer ("tonsil cancer") harbour a common type of human papilloma virus (HPV16), but also that such cancers are very sensitive to radiation. For some patients, this may mean successful treatment with radiation alone and avoiding the side effects of chemotherapy.

4 Nov 2009

Propylene glycol in e cigarettes might keep us healthy, says researchers

According to the Centers for Disease Control, during 2000-2004, "An estimated 443,000 persons in the United States died prematurely each year from smoking or exposure to secondhand smoke.

4 Nov 2009

Tonsil cancer patients harbouring HPV16 can avoid chemotherapy

4 Nov 2009

H1N1 vaccine: Discussions and debates

You can't avoid H1N1 media coverage. It's front-page news on the web, the presses, the airways. Vaccine details, or lack of, are spurring discussion and debate. And a lot of people are in a quandary about whether or not to have the H1N1 shot based on their personal views and the information disseminated for public knowledge.

4 Nov 2009

U.S. clinical trials show single dose of H1N1 vaccine protects pregnant women, children under 10 need two doses

U.S. government data released on Monday confirmed that a single dose of the vaccine protects pregnant women from the virus, while children under the age of 10 years need two doses of the vaccine, the Washington Post reports. The findings came the same day that a team of experts tasked with monitoring the national H1N1 vaccine campaign for any adverse side effects met for the first time.

4 Nov 2009

Department of Health: CDC has allocated 964,100 doses of H1N1 vaccine to Pennsylvania to date

The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 964,100 doses of H1N1 vaccine to Pennsylvania to date, the state Department of Health announced today.

4 Nov 2009

Virology News and Research

Latest Virology News and Research

Japanese data suggests a protocol for schools to follow during H1N! pandemic

Phadia offers ImmunoCAP, a reliable test to accurately diagnose the severity of egg allergy

Online self-assessment tool on MayoClinic.com helps assess flu symptoms

NIAID funds CCHI and IMVC programs to help identify new vaccines for emerging infectious diseases

USPTO awards Peregrine Pharmaceuticals patent for anti-viral uses of phosphatidylserine targeting antibodies

House legislation seeks 5 days of sick leave for workers

One Health Commission summit to focus on emerging infectious diseases

News outlets examine international efforts to contain H1N1

Medivir presents OPERA-1 Phase IIa trial data at the AASLD meeting

Henry Schein announces record financial results for third quarter 2009; reports net sales growth in local currencies

Study results of nucleoside polymerase and protease inhibitor combination therapy for HCV promising

Hospitalization and death of H1N1 patients can occur at all ages, says study

Five-year old Pennsylvanian boy dies of H1N1 flu complications

H1N1 has increased focus on effect of hygiene on health

Some patients with tonsil cancer can be treated with radiation, says PMH study

Propylene glycol in e cigarettes might keep us healthy, says researchers

Tonsil cancer patients harbouring HPV16 can avoid chemotherapy

H1N1 vaccine: Discussions and debates

U.S. clinical trials show single dose of H1N1 vaccine protects pregnant women, children under 10 need two doses

Department of Health: CDC has allocated 964,100 doses of H1N1 vaccine to Pennsylvania to date

Microplate-based assays in virology research eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging